Aardvark Therapeutics, Inc. Common Stock

$4.29
-0.07 (-1.61%)

Volume:

143.771K ($618.20K)

Market Capitalization:

$93.59M

Aardvark Therapeutics Price Chart

Aardvark Therapeutics Price Chart9:19 AM10:39 AM11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM4.474.424.374.334.284.234.18

Aardvark Therapeutics Volume Chart

Aardvark Therapeutics Volume Chart9:19 AM10:39 AM11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM9.53K8.17K6.81K5.45K4.09K2.72K1.36K

Aardvark Therapeutics Market Segments

After Hours

+0.00(+0.00%)
Open$4.29
Close$4.29
Low$4.29
Low Change0.00 (0.00%)
High$4.29
High Change+0.00 (+0.00%)
Range$0.00
Volume1.259K
Dollar Volume$5.40K

Regular Trading Hours

-0.11(-2.49%)
Open$4.41
Close$4.30
Low$4.18
Low Change-0.23 (-5.22%)
High$4.47
High Change+0.06 (+1.36%)
Range$0.29
Volume142.512K
Dollar Volume$612.80K

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

+0.04(+0.93%)
Open$4.32
Close$4.36
Low$4.32
Low Change0.00 (0.00%)
High$4.68
High Change+0.36 (+8.22%)
Range$0.36
Volume114.626K
Dollar Volume$499.77K

Premarket Yesterday

*No Trades in Segment

Aardvark Therapeutics Moving Averages

5 Day Moving Average (SMA5)$5.32
10 Day Moving Average (SMA10)$5.53
20 Day Moving Average (SMA20)$5.47
50 Day Moving Average (SMA50)$4.89
100 Day Moving Average (SMA100)$8.72
200 Day Moving Average (SMA200)$10.11

Aardvark Therapeutics Statistics

Average Volume (30 Days)171.85K
P/E Ratio (Current)-1.36
EPS (Current)-$3.20
Dividend Yield0.00%
Free Cash Flow-$61.75M
Cash Ratio5.38
Current Ratio8.06
Quick Ratio8.06
Debt to Equity0.00
Enterprise Value$32.68M
EV to EBITDA-0.44
EV to Sales
Price to Book1.09
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.71%
Return on Equity-0.80%

Aardvark Therapeutics Stock Splits

There has been 1 stock split for Aardvark Therapeutics (AARD). The reverse stock split occured on July 21, 2008 and reduced the outstanding shares at a ratio of 2:1.

DateTypeRatio
Jul 21, 2008Reverse2:1

Aardvark Therapeutics Dividends

There have been no dividends for Aardvark Therapeutics (AARD).